Member

Amendment 713C, tabled by the noble Baroness, Lady Lawlor, seeks to establish a statutory regime for companies producing and supplying substances used for assisted dying. It would restrict production, importation, distribution and supply to pharmaceutical companies registered with and authorised by the MHRA and limit the number of such authorised companies. The amendment would require the MHRA to inspect companies and be satisfied about a wide range of matters, including safety of staff, record-keeping, storage, environmental protection and other safeguards. Several inspection requirements fall outside the MHRA’s remit, including workplace safety and environmental protection. Limiting the number of manufacturers based on prior year prescriptions—